FDA advisers decided in a 19-0 vote Thursday to endorse Moderna COVID-19 booster shots for the most vulnerable to severe complications.
FDA advisers decided in a 19-0 vote Thursday to endorse Moderna COVID-19 booster shots for the most vulnerable to severe complications.